{
    "Case ID": "087560",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "cost_awards": [
                "awarded costs based on the upper end of Column IV, with adjustments for abandoned claims and the remedies phase, but increased due to settlement offers"
            ],
            "infringement_analysis": [
                "patent infringement dispute over Canadian Patent No. 1,341,206 involving ramipril drug"
            ],
            "procedure_followed": [
                "trial held without bifurcation; post-trial submissions on costs; consideration of settlement offers and abandoned claims"
            ],
            "discretion_exercise": [
                "court has discretion over cost awards, considering factors like success, complexity, and settlement offers"
            ],
            "result_of_case": [
                "Apotex awarded costs with specific adjustments, reflecting the court's discretionary assessment under Rule 400"
            ]
        }
    ]
}